LENACAPAVIR SODIUM

UNII:	BDT58WJ9WE
Type:	INGREDIENT SUBSTANCE
Formula:	C₃₉H₃₁ClF₁₀N₇O₅S₂.Na
Preferred Substance Name:	LENACAPAVIR SODIUM
InChIKey:	SSXPGMNGIORJAQ-PZNXWHLTSA-M
GSRS Full Record:	BDT58WJ9WE i

2283356-12-5
1H-CYCLOPROPA(3,4)CYCLOPENTA(1,2-C)PYRAZOLE-1-ACETAMIDE, N-((1S)-1-(3-(4-CHLORO-3-((METHYLSULFONYL)AMINO)-1-(2,2,2-TRIFLUOROETHYL)-1H-INDAZOL-7-YL)-6-(3-METHYL-3-(METHYLSULFONYL)-1-BUTYN-1-YL)-2-PYRIDINYL)-2-(3,5-DIFLUOROPHENYL)ETHYL)-5,5-DIFLUORO-3B,4,4A,5-TETRAHYDRO-3-(TRIFLUOROMETHYL)-, SODIUM SALT (1:1), (3BS,4AR)-
GS-6207-02
GS-HIV SODIUM
Lenacapavir sodium
Lenacapavir sodium [MI]
Lenacapavir sodium [USAN]
Lenacapavir sodium [WHO-DD]
N-((1S)-1-(3-(4-CHLORO-3-(METHANESULFONAMIDO)-1-(2,2,2-TRIFLUOROETHYL)-1H-INDAZOL-7-YL)-6-(3-(METHANESULFONYL)-3-METHYLBUT-1-YN-1-YL)PYRIDIN-2-YL)-2-(3,5-DIFLUOROPHENYL)ETHYL)-2-((3BS,4AR)-5,5-DIFLUORO-3-(TRIFLUOROMETHYL)-3B,4,4A,5-TETRAHYDRO1H-CYCLOPROPA(3,4)CYCLOPENTA(1,2-C)PYRAZOL-1-YL)ACETAMIDE, SODIUM SALT (1:1)
SUNLENCA
YEZTUGO

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

LENACAPAVIR SODIUM

Synonyms and Mappings

Resources